Literature DB >> 8675207

Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal.

Z M Zheng1, S Specter.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha), an important mediator in both immune and inflammation responses, is one of the major cytokines released by activated macrophages. The present study shows that, during macrophage activation, protein tyrosine phosphorylation of STAT1 alpha and ERK2 occurred as an immediate early signal, whereas maximum TNF-alpha mRNA transcription appeared at 3 hr, precursor TNF-alpha formation at 3 to 4 hr, and TNF-alpha release at 5 to 6 hr after stimulation of an RPMI-1640-based induction medium containing lipopolysaccharide (100 ng/ml), interferon-gamma (100 U/ml), and 0.5% bovine serum albumin. Herbimycin A, a tyrosine kinase inhibitor, suppresses protein tyrosine phosphorylation of STAT1 alpha and ERK2 and also blocks TNF-alpha production by resident peritoneal macrophages from BALB/c mice, suggesting a possible association between protein tyrosine phosphorylation of STAT1 alpha and ERK2 and macrophage activation resulting in TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675207      PMCID: PMC1384131          DOI: 10.1046/j.1365-2567.1996.513591.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages.

Authors:  S L Weinstein; J S Sanghera; K Lemke; A L DeFranco; S L Pelech
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.

Authors:  Y Uehara; H Fukazawa
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.

Authors:  B Watzl; P Scuderi; R R Watson
Journal:  Int J Immunopharmacol       Date:  1991

4.  Candida albicans hyphal form enhances tumor necrosis factor mRNA levels and protein secretion in murine ANA-1 macrophages.

Authors:  E Blasi; L Pitzurra; M Puliti; A Bartoli; F Bistoni
Journal:  Cell Immunol       Date:  1992-06       Impact factor: 4.868

5.  WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.

Authors:  M K Eskandari; D T Nguyen; S L Kunkel; D G Remick
Journal:  Immunol Invest       Date:  1990-02       Impact factor: 3.657

6.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

7.  Gene regulation in macrophage activation: differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-gamma and lipopolysaccharide.

Authors:  S F Yu; T J Koerner; D O Adams
Journal:  J Leukoc Biol       Date:  1990-11       Impact factor: 4.962

8.  Production of tumor necrosis factor alpha by resident and activated murine macrophages.

Authors:  K Tachibana; G J Chen; D S Huang; P Scuderi; R R Watson
Journal:  J Leukoc Biol       Date:  1992-03       Impact factor: 4.962

9.  Neopterin augmentation of tumor necrosis factor production.

Authors:  M Barak; N Gruener
Journal:  Immunol Lett       Date:  1991-09       Impact factor: 3.685

10.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more
  8 in total

1.  STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.

Authors:  Nathan Ryan; Kelvin Anderson; Greta Volpedo; Omar Hamza; Sanjay Varikuti; Abhay R Satoskar; Steve Oghumu
Journal:  Int J Cancer       Date:  2019-11-29       Impact factor: 7.396

2.  Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.

Authors:  A Boland; G R Cornelis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.

Authors:  B H Lloyd; R V Giles; D G Spiller; J Grzybowski; D M Tidd; D R Sibson
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

Review 4.  Emerging roles for TNIP1 in regulating post-receptor signaling.

Authors:  Vincent P Ramirez; Igor Gurevich; Brian J Aneskievich
Journal:  Cytokine Growth Factor Rev       Date:  2012-04-28       Impact factor: 7.638

Review 5.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.

Authors:  Mingfang Tao; Michael Kruhlak; Shuhua Xia; Elliot Androphy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

Authors:  K Ruckdeschel; S Harb; A Roggenkamp; M Hornef; R Zumbihl; S Köhler; J Heesemann; B Rouot
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

8.  The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages.

Authors:  Anna E Karagianni; Ronan Kapetanovic; Bruce C McGorum; David A Hume; Scott R Pirie
Journal:  Vet Immunol Immunopathol       Date:  2013-07-20       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.